| J0897 | Injection, denosumab, 1 mg | 3,060 | $20 | $58.1K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 400 | $130 | $52.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 440 | $80 | $36.1K |
| 99203 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the provider… | 210 | $80 | $16K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 220 | $60 | $12.5K |
| J9155 | Injection, degarelix, 1 mg | 2,640 | $1 | $7.9K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 60 | $100 | $6.2K |
| 51720 | This is a common treatment for bladder cancer. It involves instilling an anticarcinogenic agent into the bladder through a catheter. The provider leaves the agent in the bladder for a period of time… | 50 | $60 | $3.1K |
| 51702 | The bladder catheter CPT® codes provide options for reporting the procedures that best reflect the exact anatomic location of a catheter insertion, the type of catheter inserted, and, in some cases,… | 80 | $40 | $3K |
| 96402 | In this procedure, the provider administers chemotherapy either subcutaneously, meaning under the skin, or intramuscularly, meaning in muscle. He administers a hormonal anti–neoplastic drug. | 100 | $30 | $2.6K |